The human monoblastoid tumor cell line U937 was induced to differentiate along the monocyte/macrophage lineage by treatment with 5 x 10(-9) M 12-O-tetradecanoyl phorbol-13-acetate (TPA). Between 2 h and 4 h following TPA-treatment U937 cells started to release significant amounts of TNF-alpha which remained detectable until 8-10 days. A significant IL-1 beta release was measured 24 h-48 h post stimulation and increased levels of IL-1 beta persisted until 20-22 days of culture. In contrast no release of either IL-1 alpha or IL-6 could be detected with 5 x 10(-9) M TPA during the whole time course of the experiments. The sequential induction of TNF-alpha and IL-1 beta appeared to be independently regulated since TNF-alpha release was not requ...
This study was undertaken to determine how human pancreatic cancer (HPC-4) cells transduced with the...
Background: Some ligands of pattern recognitionm receptors (PRR) are present on tumour cells. The ro...
Prostaglandin E2 (PGE2)‐mediated suppression of macrophage interleukin‐1α,β and tumor necrosis facto...
The human monoblastoid tumor cell line U937 was induced to differentiate along the monocyte/macropha...
AbstractIn the present report we compare the capacity of two related cytokines, tumor necrosis facto...
Several lines of evidence point to an activation mechanism of monocytes/macrophages by tumor cells. ...
AbstractThe treatment of human diploid fibroblasts with tumor necrosis factor (TNP)-α and with lymph...
Cells of the proerythromyeloid cell line K562 and of the T cell line Jurkat were able to induce an i...
Mono-Mac-6 cells, but not U937 cells, can be Induced to rapidly express tumor necrosis factor (TNF) ...
The regulation of the 55-kDa TNF receptor (TNF-R) mRNA synthesis, membrane expression, and TNF bindi...
Differentiation of the myeloid cell lineage towards a monocyte/macrophage has been studied using the...
In order to dissect the molecular mechanisms of monocytic differentiation we have developed a subtra...
The monocytic tumour, THP-1, expresses many of the properties of monocytes, both by cell surface sta...
Peripheral blood lymphocytes cultured in interleukin 2 (IL-2) acquire the ability to lyse tumor cell...
Tumor-associated macrophages (TAMs), the most abundant immunosuppressive myeloid cells in the tumor ...
This study was undertaken to determine how human pancreatic cancer (HPC-4) cells transduced with the...
Background: Some ligands of pattern recognitionm receptors (PRR) are present on tumour cells. The ro...
Prostaglandin E2 (PGE2)‐mediated suppression of macrophage interleukin‐1α,β and tumor necrosis facto...
The human monoblastoid tumor cell line U937 was induced to differentiate along the monocyte/macropha...
AbstractIn the present report we compare the capacity of two related cytokines, tumor necrosis facto...
Several lines of evidence point to an activation mechanism of monocytes/macrophages by tumor cells. ...
AbstractThe treatment of human diploid fibroblasts with tumor necrosis factor (TNP)-α and with lymph...
Cells of the proerythromyeloid cell line K562 and of the T cell line Jurkat were able to induce an i...
Mono-Mac-6 cells, but not U937 cells, can be Induced to rapidly express tumor necrosis factor (TNF) ...
The regulation of the 55-kDa TNF receptor (TNF-R) mRNA synthesis, membrane expression, and TNF bindi...
Differentiation of the myeloid cell lineage towards a monocyte/macrophage has been studied using the...
In order to dissect the molecular mechanisms of monocytic differentiation we have developed a subtra...
The monocytic tumour, THP-1, expresses many of the properties of monocytes, both by cell surface sta...
Peripheral blood lymphocytes cultured in interleukin 2 (IL-2) acquire the ability to lyse tumor cell...
Tumor-associated macrophages (TAMs), the most abundant immunosuppressive myeloid cells in the tumor ...
This study was undertaken to determine how human pancreatic cancer (HPC-4) cells transduced with the...
Background: Some ligands of pattern recognitionm receptors (PRR) are present on tumour cells. The ro...
Prostaglandin E2 (PGE2)‐mediated suppression of macrophage interleukin‐1α,β and tumor necrosis facto...